NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Celltrio

Celltrio

Private
Fremont, CaliforniaHealthcare & Life Scienceshttps://celltrio.com/

Last Round

Early Funding

Jun 17, 2025

Total Funding Raised

$15M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Celltrio is a biotechnology company that develops and manufactures robotic-based solutions and modular lab automation systems for the life sciences industry.

Sector

Healthcare & Life Sciences

Verticals

Biotech Equipment, Biotechnology, Industrial Robotics, Drug Discovery, Workflow Automation

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Non-AI

Keywords

lab automationcell culture automationbiobankingrobotic cell cultureautomated liquid handlingcryogenic storagecell line developmentbiotech roboticsgood manufacturing practiceGMPworkflow automationcell therapy manufacturinglab-in-a-boxautomated labdrug discovery tools

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Celltrio Comps

Public and private peers based on sector, stage, and business model.

Celltrio comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Celltrio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Early FundingJun 17, 2025

Key People

Founding team and executive leadership

Jeff Baird

Chief Operating Officer

Executive Team

Celltrio Investors

Notable investors and investment history

Celltrio investors
InvestorRounds
Asia2G CapitalEarly Funding
Premier PartnersEarly Funding

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 19, 2026

    Monthly visitors grew 184% MoM, reaching 3K.

  • Jun 17, 2025

    $15M round completed.

Celltrio Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Celltrio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Celltrio's valuation, stock price, and market status.

Firmographic Details

HeadquartersFremont, California
Employee Range32
Year Founded2018
Last FundingJun 17, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.